88.10
-0.50
(-0.56%)
At close: 1:30:26 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,257,665
1,257,665
1,114,687
986,300
893,233
Cost of Revenue
770,724
770,724
705,166
618,302
601,881
Gross Profit
486,941
486,941
409,521
367,998
291,352
Operating Expense
135,957
135,957
127,632
129,769
122,766
Operating Income
350,984
350,984
281,889
238,229
168,586
Net Non Operating Interest Income Expense
18,173
18,173
23,992
10,094
-1,133
Pretax Income
488,238
488,238
313,769
355,237
200,229
Tax Provision
94,954
94,954
62,756
59,949
23,069
Net Income Common Stockholders
393,284
393,284
251,013
295,288
177,160
Diluted NI Available to Com Stockholders
393,284
393,284
251,013
295,288
177,160
Basic EPS
8.82
--
5.63
6.62
5.03
Diluted EPS
8.80
--
5.62
6.61
5.02
Basic Average Shares
44,590.02
--
44,584.90
44,605.44
35,249
Diluted Average Shares
44,691.36
--
44,664.24
44,672.92
35,284
Total Expenses
906,681
906,681
832,798
748,071
724,647
Net Income from Continuing & Discontinued Operation
393,284
393,284
251,013
295,288
177,160
Normalized Income
393,428.99
393,428.99
251,043.40
295,288
177,160
Interest Income
20,314
20,314
29,730
16,014
2,258
Interest Expense
2,141
2,141
5,738
5,920
3,391
Net Interest Income
18,173
18,173
23,992
10,094
-1,133
EBIT
490,379
490,379
319,507
361,157
203,620
EBITDA
634,373
634,373
431,261
442,005
275,072
Reconciled Cost of Revenue
770,724
770,724
705,166
618,302
601,881
Reconciled Depreciation
143,994
143,994
111,754
80,848
71,452
Net Income from Continuing Operation Net Minority Interest
393,284
393,284
251,013
295,288
177,160
Total Unusual Items Excluding Goodwill
-180
-180
-38
--
--
Total Unusual Items
-180
-180
-38
--
--
Normalized EBITDA
634,553
634,553
431,299
442,005
275,072
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-35.01
-35.01
-7.60
--
--
12/31/2021 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8279.TWO Syngen Biotech Co.,Ltd.
122.50
-0.41%
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
27.90
-1.06%
4162.TWO PharmaEngine, Inc.
87.10
-2.35%
6846.TWO Greenyn Biotechnology Co., Ltd
70.10
+0.43%
3205.TWO Sagittarius Life Science Corp
23.60
-1.05%
1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.95
+0.16%
4911.TWO G&E Herbal Biotechnology Co., Ltd.
50.00
+0.20%
3118.TWO Level Biotechnology Inc.
31.35
-0.95%
4728.TWO Sunmax Biotechnology Co., Ltd.
417.00
+4.77%
3164.TW GenMont Biotech Incorporation
19.30
-3.26%